460 likes | 469 Views
Explore a momentous event in business history with detailed financial figures and strategic plans for six significant companies within the Lalbhai Group. Dive into their key initiatives and market positioning.
E N D
Welcome July 6, 2007
Sales Rs cr 895 814 681 566
Profit from operations Rs cr 62 62 43 34 33 31 15 7 PBDT* PBT* Excluding VRS
Position of Borrowings 2006-07 Rs cr Note: One loan of US$5.5 m availed end of March has been parked partly as short term FDR amounting to Rs16 cr carrying 11.25% p.a. interest rate.
Gross Block Rs cr
AG Salient features • 3rd largest producer of 2,4D in the world • Increasing domestic distribution network • Increasing input prices • Reducing formulation margins • Shrinking demand in Indian market Strategic actions planned | under implementation • Increase brand business • Reduce variable cost of production • Introduce value added products • Enter high price markets
AR Salient features • Global leader in 3 major products • Increasing input prices • Margins under pressure for commodity business Strategic actions planned | under implementation • Increase capacity of existing value added products • Enter high price markets • Introduce more value added products
BI Salient features • Volatile selling prices • Margins under pressure being commodity business Strategic actions planned | under implementation • Introduce value added down stream products of • Increase capacity of Resorcinol • Achieve cost reduction through improved technology
CO Salient features • Established player in VAT dyes • Increasing input prices • Increasing domestic consumption Strategic actions planned | under implementation • Acquire synergistic vat finishing capacity • Reorganise marketing setup • Introduce new value added products • Increase sourcing activity • Introduce high performance pigments
PI Salient features • Global leader in one major product • High contribution margin Strategic actions planned | under implementation • Increase capacity of 2 major products • Introduce new phosgene based products • Introduce several other intermediates pharma inters and APIs
PO Salient features • Increasing input prices • Margins under pressure for commodity business Strategic actions planned | under implementation • Reorganise marketing set-up • Expand capacity of BLR • Introduce brands
Capex Rs cr
Value Added Products (Launched)
Value Added Products (Pipeline)